Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000348520

Medchemexpress LLC Daurk-4 hydrochloride | 99.4% | 1071.93 | 50 MG
SDP

Catalog No. 5000348520
Encompass_Preferred

dAURK-4 hydrochloride is a potent and selective PROTAC AURKA (Aurora A) degrader, derived from Alisertib. This compound exhibits anticancer effects by targeting specific proteins involved in cell proliferation. It is composed of a ligand for the target protein, a linker, and a ligand for the E3 ligase Thalidomide-O-COOH, enabling dose-dependent degradation of AURKA in vitro.

  • Potent and selective PROTAC AURKA degrader
  • Derivative of Alisertib
  • Exhibits anticancer effects
  • Composed of specific ligands and a linker for targeted degradation
  • Demonstrates dose-dependent degradation of AURKA in vitro
  • High purity (99.44%)

Catalog No. 50-003-48520 Supplier Medchemexpress LLC Supplier No. HY137344A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

dAURK-4 hydrochloride is a potent and selective PROTAC AURKA (Aurora A) degrader, derived from Alisertib. This compound exhibits anticancer effects by targeting specific proteins involved in cell proliferation. It is composed of a ligand for the target protein, a linker, and a ligand for the E3 ligase Thalidomide-O-COOH, enabling dose-dependent degradation of AURKA in vitro.

  • Potent and selective PROTAC AURKA degrader
  • Derivative of Alisertib
  • Exhibits anticancer effects
  • Composed of specific ligands and a linker for targeted degradation
  • Demonstrates dose-dependent degradation of AURKA in vitro
  • High purity (99.44%)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.